Target
Cannabinoid receptor 2
Ligand
BDBM50356550
Substrate
n/a
Meas. Tech.
ChEMBL_776031 (CHEMBL1912501)
Ki
1.3±n/a nM
Citation
 Piscitelli, FLigresti, ALa Regina, GGatti, VBrizzi, APasquini, SAllarà, MCarai, MANovellino, EColombo, GDi Marzo, VCorelli, FSilvestri, R 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligands. Eur J Med Chem 46:5641-53 (2011) [PubMed]  Article 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM50356550
Synonyms:
CHEMBL1909858
Type:
Small organic molecule
Emp. Form.:
C21H20Cl4N4O
Mol. Mass.:
486.222
SMILES:
Cc1c(nn(c1-n1c(Cl)ccc1Cl)-c1ccc(Cl)c(Cl)c1)C(=O)NC1CCCCC1 |(33.16,-36.05,;34.06,-37.29,;35.6,-37.3,;36.07,-38.76,;34.82,-39.66,;33.58,-38.75,;32.11,-39.21,;30.88,-38.28,;30.9,-36.74,;29.62,-39.16,;30.07,-40.64,;31.61,-40.66,;32.5,-41.92,;34.82,-41.2,;33.48,-41.96,;33.48,-43.5,;34.81,-44.27,;34.81,-45.81,;36.15,-43.5,;37.49,-44.27,;36.15,-41.96,;36.5,-36.05,;35.88,-34.64,;38.03,-36.21,;38.94,-34.97,;40.47,-35.14,;41.38,-33.9,;40.76,-32.49,;39.22,-32.32,;38.31,-33.57,)|
Structure:
Search PDB for entries with ligand similarity: